絞り込み

16645

広告

Alfa and beta estrogen receptors and the biliary tree.

著者 Alvaro D , Alpini G , Onori P , Franchitto A , Glaser SS , Le Sage G , Folli F , Attili AF , Gaudio E
Mol Cell Endocrinol.2002 Jul 31 ; 193(1-2):105-8.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

Division of Gastroenterology, Department of Clinical Medicine, University of Rome 'La Sapienza', Via valsolda 45/i, 00141 Rome, Italy. alvaro@axrma.uniromal.it

スターを付ける スターを付ける     (56view , 0users)

Full Text Sources

Miscellaneous

Other Literature Sources

This manuscript summarizes recent data showing that estrogens and their receptors play an important role in modulating cholangiocyte proliferation. We have recently demonstrated that rat cholangiocytes express both estrogen receptors (ER)-alpha and -beta subtypes, while hepatocytes only express ER-alpha. ER and especially the ER-beta subtype, are overexpressed in cholangiocytes proliferating after bile duct ligation (BDL) in the rat, in association with enlarged bile duct mass and with enhanced estradiol serum levels. Cholangiocyte proliferation, during BDL, is impaired by estrogen antagonists (tamoxifen, ICI 182,780) which furthermore, induce the overexpression of Fas antigen and activate apoptosis of proliferating cholangiocytes. 17beta-estradiol stimulates, in vitro cholangiocyte proliferation, and this effect is individually blocked by tamoxifen or ICI 182,780. Cholangiocyte proliferation during BDL was associated with an enhanced protein expression of phosphorylated extracellular regulated kinases (ERK)1/2 which is, in contrast, negatively modulated by tamoxifen in association with its antiproliferative effect. This indicates a major involvement of the ERK system in the estrogen modulation of cholangiocyte proliferation.
PMID: 12161009 [PubMed - indexed for MEDLINE]
印刷用ページを開く Endnote用テキストダウンロード